News
Illumina expects that adding SomaLogic will aid its “multiomics” business strategy and strengthen the value of its gene ...
Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein ...
Standard BioTools (NASDAQ:LAB) shares jumped as much as 19% premarket on Monday after the company announced the sale of its SomaLogic business to Illumina (NASDAQ:ILMN) for an aggregate cash ...
Li Qing (left), senior vice-president of Illumina and general manager the company's China operation, shows reporters around the company's newly launched manufacturing site in Shanghai. [Photo provided ...
A novel device involving the cell lysis and DNA amplification performed in a single step have been proposed by Ke et al. (2007). A simple and rapid protocol for the preparation of total genomic DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results